Gilead Sciences
An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 15 trials in this atlas.
- Organization
- In this atlas
Overview
Technical summary
Sponsor class industry. No ROR record matches the name exactly.
Trials at a glance
These figures count only the registry trials in this atlas that name Gilead Sciences as a sponsor: 15 trials, 11 as lead sponsor and 4 as collaborator.
Phase and status
| Phase | Completed | Terminated | Unknown status | All statuses |
|---|---|---|---|---|
| Phase 2 | 6 | 0 | 0 | 6 |
| Phase 2/3 | 0 | 1 | 0 | 1 |
| Phase 3 | 6 | 0 | 0 | 6 |
| Phase 4 | 1 | 0 | 1 | 2 |
| All phases | 13 | 1 | 1 | 15 |
Start year
| Start year | Trials |
|---|---|
| 2021 | 1 |
| 2019 | 1 |
| 2015 | 2 |
| 2014 | 3 |
| 2012 | 3 |
| 2011 | 4 |
| 2010 | 1 |
Main conditions
Main countries
- United States
- Canada
- Germany
- Poland
- Czechia
Roles
- Company
- Sponsor
Sector
Industry
The registry's words
Labels as the registry gives them, not rewritten.
- Sponsor name
- Gilead Sciences
- Sponsor class
- INDUSTRY
Registry records
Assembled by a program from ClinicalTrials.gov. No person wrote or checked these pages, and they are counted apart from the pages that people wrote. Lists of trials come from the registry's own coding and may miss trials.
Registry trials 15
Record details
- Record id
cardio:org-gilead-sciences- Content hash
a5fe7464f39b16984a6fb27322626d13623697a87c4b8f0ce8d3f00b89b1698b